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Abstract  
 
Introduction 
In spite of consistent scientific documentation of the beneficial effects of exercise training 
programs in coronary artery disease (CAD), exercise training is a remarkably underutilized 
(1) and probably also undervalued treatment option. CAD is an inflammatory disorder linking 
inflammation in the vessel wall to endothelial dysfunction and progression of disease (2). The 
aim of this study was to explore the effects of a high-intensity interval training program on the 
late luminal loss and the associated risk of restenosis, plasma levels of inflammatory markers, 
endothelial function and the cardiac autonomic nervous system.  
Further, percutaneous coronary intervention (PCI) can be regarded as a model for mechanical 
induced plaque rupture. An additionally objective was therefore the evaluation of the 
inflammatory response to PCI reflected by plasma levels of numerous inflammatory 
mediators. 
 
Methods 
Subjects 
Forty consecutive patients were included after successful PCI with stent implantation in one 
or several native coronary arteries because of angina pectoris. Patients were randomly 
assigned to an organized training program for 6 months or to usual care. 
Exercise Training  
A high-intensity interval group training for 60 minutes three times a week was used, starting 
11±4 days after PCI. Individual pulse watches allowed the patients to monitor their heart rate 
and exercise intensity during training. 
Quantitative coronary angiography 
At 6 months follow-up, coronary reangiography with repetition of identical angiographic 
projections of the lesion was performed. A validated computer-assisted edge-detection 
algorithm was used to measure late luminal loss defined as the minimal lumen diameter 
immediately after the procedure minus the minimal lumen diameter at 6 months follow-up. 
Exercise Testing 
Symptom-limited ergospirometry was performed on an upright, electrically braked cycle 
ergometer using a 20 Watt/minute ramp protocol. The patients were asked to exercise to 
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exhaustion. Gas exchange data were collected continuously with an automated breath-by-
breath system.  
Endothelial Function 
Endothelium-dependent and endothelium-independent dilation of the brachial artery was 
measured using a 12-MHz ultrasound Doppler probe according to current guidelines (3). 
 
Inflammatory markers 
High-sensitivity CRP concentrations were measured by a particle-enhanced immunoturbidi-
metric method with the use of Roche Modular P automated clinical chemistry analysers 
(Roche Diagnostics). Plasma concentrations of interleukin-(IL)-6, IL-10, pentraxin 3 (PTX3), 
tumor necrosis factor (TNF), vascular cell adhesion molecule (VCAM)-1, E-selectin, P-
selectin, monocyte chemoattractant protein (MCP)-1/CCL2, regulated on activation, normal T 
cell expressed and secreted (RANTES/CCL5), CCL19, CCL21, IL-8/CXCL8 and CXCL16 
were quantified by enzyme immunoassays (EIAs) obtained from R&D Systems (Minneapolis, 
MN). Plasma concentrations of von Willebrand factor (vWF) were analyzed by EIA using 
antibodies from DakoCytomation (Glostrup, Denmark). Plasma concentrations of CD40 
ligand (CD40L) were analyzed by EIA provided by Bender MedSystems GmbH (Vienna, 
Austria).  
Heart Rate Variability 
Heart rate variability (HRV) measures were obtained from a 3-channel portable Holter 
(Schiller MT-200, Switzerland) worn for 24 hours. The MT-210 Analysis Software Version 
1.0.0 (Schiller) was used to analyse time and frequency domain measures of HRV. 
 
Results 
At six months in-stent restenosis, measured as in-segment late luminal loss of the stented 
coronary area, was significant smaller in the training group compared to the control group. 
This effect was associated with a significant increased peak oxygen uptake and improved 
brachial artery reactivity in the training group only.  
In the training group all time domain indices and the frequency domain indices, total power 
and ultralow frequency of HRV, increased significantly during the training period, while 
mean heart rate decreased significantly. In the control group only one time domain measure 
index increased significantly.  
Plasma levels of CRP and PTX3 showed a significantly early increase after PCI peaking at 3 
days and 3 hours, respectively. VCAM-1 increased significantly with a peak at 3 days, while 
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E-selectin showed a significant gradual decrease. Markers of platelet mediated inflammation 
showed increasing (CD40 ligand) and decreasing (P-selectin) levels after PCI. While plasma 
levels of MCP, CCL21 and CXCL16 increased rapidly in response to PCI, IL-8, CCL19 and 
RANTES decreased. 
At 6 months, levels of the inflammatory markers CRP, IL-6 and IL-8 were significantly 
reduced and levels of the anti-inflammatory cytokine IL-10 were significantly increased in the 
training group only. The changes of CRP and IL-6 from baseline to 6 months were 
significantly correlated to late luminal loss in the stented segment at 6 months. In contrast to 
these anti-inflammatory effects, training had no effect on markers of platelet-mediated 
inflammation, and the effect of training on markers on endothelial cell activation were rather 
complex showing attenuating (vWF) and enhancing (E-selectin and VCAM-1) effects..  
 
 
Conclusion 
Regular high-intensity interval exercise training over 6 months resulted in a significant 
reduction in late luminal loss in the stented coronary segment after PCI for angina pectoris. 
This effect was associated with increased aerobic capacity, improved endothelium function 
and improved heart rate variability. PCI induced a complex response of plasma levels of 
inflammatory markers and cytokines during the first week post-PCI.  
Regular exercise training in non-acute stable angina patients following PCI may attenuate 
some, but not all inflammatory pathways, potentially contributing to the beneficial effects of 
exercise training on restenosis. 
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1. Introduction 
 
Despite the improvements of treatment strategies for hypercholesterolemia and hypertension, 
CAD remains the leading cause of death globally (4). These facts force us to continue 
research on cardiovascular disease and consider new strategies for prevention, treatment and 
rehabilitation of this prevalent disease. 
 
1.1 Coronary artery disease and exercise 
CAD is an inflammatory disease with accumulation of lipids in atheromatous plaques within 
the walls of the coronary arteries. Many of the independent risk factors for CAD like 
hypertension, dyslipidemia, diabetes and smoking are related to a sedentary lifestyle. 
Overweight has reached epidemic proportions also in Norway, where about 20% of the 
Norwegian adult population is considered obese (5). 
Regular exercise training as a treatment modality has the ability to improve risk factor profile 
as training has been shown to improve glygemic control, lipid profile, blood pressure and 
body weight in different patient populations (6-8). 
Current guidelines recommend all patients with CAD to exercise 3-5 days a week at 50-80% 
of exercise capacity for 20-60 minutes (9). Although the beneficial effects of exercise training 
in primary and secondary prevention of cardiovascular disease are well documented (10, 11), 
exercise training as a treatment modality is currently remarkably underutilized (1).  
Recently, high-intensity aerobic interval training has been shown to be superior to moderate 
continuous exercise training in improving exercise capacity and endothelial function in 
patients with CAD, ischemic cardiomyopathy and metabolic syndrome (12-14).  
 
1.2 Restenosis 
PCI with stent implantation is the therapy of choice in patients with symptomatic CAD related 
to significant stenosis, not eligible to coronary artery bypass grafting (CABG). Although PCI 
and CABG may be comparable treatment strategies, restenosis remains the Achilles’ heel of 
PCI.  
Late loss in lumen diameter is monotonically related to the risk of restenosis in published 
stent trials and is a generalizable and powerful angiographic end point in stent trials (15). In 
stented arteries late luminal loss correlates primarily with intimal hyperplasia (16). Neointima 
is composed of proliferating smooth muscle cells and excessive production of extracellular 
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matrix (17). The formation of neointimal hyperplasia after PCI has been linked to persistent 
low local shear stress (18), to the inflammatory response to the vessel injury with increased 
levels of CRP (19) and to genetic factors involving regulation of smooth muscle cell and 
leukocyte proliferation in vascular disease (20). 
The use of drug eluting stents (DES) has markedly reduced the restenosis rate (21), but 
efficiency and safety issues with regard to late and very late stent thrombosis are still under 
investigation in large randomized controlled trials. 
 
1.3 Inflammation 
Inflammation plays a key role in  atherosclerosis (2). Immune cells accumulate early in 
atherosclerotic lesions and their effector molecules accelerate progression of the lesions (2). 
CAD  is an inflammatory disorder, in which immune mechanisms interact with metabolic risk 
factors to initiate, propagate and activate lesions in the arterial tree (2). 
Atheromata are asymmetric focal thickening of the intima consisting of lipids, connective 
tissue, debris and different cells as vascular endothelial cells, smooth muscle cells and blood-
borne inflammatory cells like macrophages and T-cells (2, 22).  
In the centre of an atheroma, foam cells and extracellular lipid droplets form a core region, 
which is surrounded by a cap of smooth-muscle cells and a collagen-rich matrix. T cells, 
macrophages and mast cells infiltrate the lesion and are particularly abundant in the shoulder 
region, where the atheroma grows (23, 24). Many of these immune cells show signs of 
activation and produce inflammatory cytokines (24), which may play an important 
pathophysiologic role for the development of the atheroma. The activation of a plaque with 
rupture of the cap can cause formation of a thrombus on the luminal surface of the plaque, 
resulting in an acute cardiovascular event. 
In the current trial we studied the inflammatory response to PCI, which cause endothelial 
damage and barotrauma to the vessel wall. There are data indicating that this inflammatory 
response is of clinical importance, as it might be associated with the development of 
restenosis and increased risk for future coronary events (19, 25).  
Further, the PCI procedure can be regarded as a model for mechanical induced plaque rupture. 
Thus, studies on the inflammatory reaction during PCI could give information on immune-
mediated mechanisms during plaque destabilization.  
The inflammatory response during PCI includes a complex interaction between endothelial 
cells, platelets and leukocytes, and involves a multitude of inflammatory mediators in a 
multifaceted network. Most studies on inflammation during PCI have focused on relatively 
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few mediators, primarily representing downstream markers of inflammation (e.g., CRP) and 
established upstream inflammatory mediators (e.g., IL-6, IL-1 and TNF) (26, 27).  We 
analyzed besides “classical” markers of inflammation, markers of endothelial cell activation, 
markers of platelet derived inflammation as well as chemokines that attract leukocytes to 
inflamed tissue. 
Additionally, we were interested in the “anti-inflammatory” effect of regular exercise training 
as exercise training may lower the risk for CAD by attenuating inflammation and improving 
endothelial function. 
 
1.4 Cardiac autonomic function 
The autonomic nervous system is the part of the peripheral nervous system that controls key 
functions of visceral organs. It is classically divided into the parasympathetic nervous system 
and sympathetic nervous system. 
The part of the autonomous nerve system affecting the heart comes from sympathetic ganglia 
running adjacent to the upper thoracic spinal column and the adrenal medulla. The 
parasympathetic innervation of the heart is mediated by dedicated cardiac branches of the 
vagus nerve and thoracic spinal accessory nerves (28). 
Heart rate variability (HRV) measurements provide a non-invasive method to assess cardiac 
autonomic function. HRV increases with higher parasympathetic tone and decreases with 
sympathetic stimulation. Thus, higher HRV implies augmentation of parasympathetic tone, 
which might be protective against cardiac morbidity and mortality (29). 
CAD is associated with cardiac autonomic imbalance reflected by low HRV. Low HRV is a 
negative prognostic factor for mortality and the risk for cardiac events in the general 
population (29). Data on the prognostic value of HRV in CAD without myocardial infarction 
(MI) or heart failure are limited. In healthy subjects exercise training results in a decrease of  
resting heart rate, believed to be caused by an increase in the parasympathetic tone (30). A 
meta-analysis showed that exercise training leads to improvements in HRV in patients with 
CAD (31). However, none of the randomized controlled trials published so far, have 
evaluated the effect of a high-intensity interval training program following revascularization 
with PCI and stent implantation in patients with CAD free of MI or heart failure.  
Further, little is known about the mechanisms of the association between exercise training, 
autonomic imbalance and clinical outcome. 
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Therefore, we assessed the effect of a high-intensity interval training program on different 
day- and night- time measures of HRV. Further, we were interested in potential associations 
to changes in exercise capacity, endothelial function and inflammation. 
 
 
“If we can selectively modify the harmful components of inflammation in the 
arteries and leave the protective aspects intact, we may create new avenues for 
the diagnosis and management of disease in the 50 percent of patients with 
cardiovascular disease who do not have hypercholesterolemia” 
 
Russell Ross 
 
 
 
 
 
 
2. Aims of the thesis 
 
1. To explore the effect of a regular high-intensity interval training on late luminal loss 
and the risk of restenosis in patients revascularized by PCI with stent implantation for 
angina pectoris 
2. To evaluate the effect of this training model on aerobic capacity, endothelial function 
and plasma levels of C-reactive protein and to assess potential correlations between 
late luminal loss, endothelial function, plasma levels of C-reactive protein and aerobic 
capacity 
3. To assess the effect of a high-intensity interval training program on cardiac autonomic 
function reflected by time and frequency domain measures of heart rate variability 
4. To explore the effect of PCI as a model of mechanical induced plaque rupture on 
plasma levels of selected inflammatory mediators 
5. To evaluate the response of a high-intensity interval training program on levels of 
markers of inflammation and endothelial cell activation in patients revascularized for 
coronary artery disease 
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3. Subjects and Methods 
3.1 Study population 
Patients referred for planned coronary angiography at the Department of Cardiology, 
Stavanger University Hospital, were screened for eligibility before angiography. 
After successful PCI in one or several native coronary arteries, which was defined as a 
residual diameter stenosis after stent implantation of less than 20% of the reference diameter, 
40 consecutive patients were included. Exclusion criteria included a history of MI or CABG, 
restenosis after previous PCI, significant valvular heart disease, age over 80 years, inability to 
give informed consent, inability to participate in regular training due to residency, work 
situation or comorbidity, any known chronic inflammatory disease other than atherosclerosis, 
persisting or permanent atrial fibrillation or planned surgery within the next 6 months. 
Patients were randomized to either a high-intensity interval training program for 6 months or 
to usual care.  
The study was performed according to the Helsinki declaration. The local ethics committee 
approved the protocol and all patients gave written informed consent. 
During the inclusion period 224 patients matched the inclusion criterion “successful PCI” 
with stenting in a native coronary artery for angina pectoris. Reasons for exclusion were 
inability to participate in regular training due to residency (to far from the training facility) 
(n=89), work situation (not able to participate in training sessions in the morning due to job) 
(n=13) or comorbidity (n=24), history of MI or CABG (n=32), heart failure (n=3), age over 
80 years (n=6), malignancy or planned surgery within the next 6 months (n=5), significant 
valvular heart disease (n=3), known chronic inflammatory disease (n=6) or refusal to 
participate (n=3). 
 
3.2 Exercise Training 
The exercise training program was designed based on recently published data confirming the 
superior effect of aerobic high-intensity interval training in cooperation with two experienced 
physical therapists specialised in cardiac rehabilitation (13, 14). The patients exercised in 
groups of 10, starting 11±4 days after PCI, for one hour three times a week for six months. 
The training model included 10 minutes of warm-up at 60-70 % of maximal heart rate, 
followed by four 4-minutes intervals at 80-90 % of maximal heart rate, when patients were 
riding an ergometric bicycle or were running. Intervals were interrupted by 3 minutes of 
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active recovery at 60-70 % of maximal heart rate. The interval training period was followed 
by 5 minutes cool-down, 10 minutes abdominal- and spine-resistance exercises and 5 minutes 
of stretching and relaxing. Patients were wearing individual pulse watches to monitor the 
intended target heart rate during training.  
 
 
 
Figure 1. Original pulse registration during interval training showing four pulse peaks. 
 
 
3.3 Quantitative coronary angiography 
Standard image acquisition was performed using 2 or more angiographic projections of the 
stenosis. Intracoronary nitroglycerin was administered to provide maximum coronary 
vasodilation. At follow-up, repetition of identical angiographic projections of the lesion were 
performed. With the contrast-filled injection catheter as the calibration source, quantitative 
angiographic analysis was performed by use of a validated computer-assisted edge-detection 
algorithm (General Electric, USA). Lesion length was defined as the axial extent of the lesion 
that contained a shoulder-to-shoulder lumen reduction by 20%. Selected images for analysis 
were identified by use of angiographic projections that demonstrated the stenosis in an 
unforeshortened view, minimized the degree of vessel overlap, and displayed the stenosis in 
its “sharpest and tightest” view. A 5-mm segment of reference diameter proximal and distal to 
the stenosis was used to calculate the average reference vessel diameter at baseline, after stent 
implantation and at follow-up. The target lesion was defined as the stented segment plus a 5 
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mm segment proximal and distal to the stent. Angiographic follow-up was performed at 6 
months after the index procedure unless earlier angiography was indicated due to clinical 
reasons. Binary angiographic restenosis was defined as the incidence of percent diameter 
stenosis of 50 % at the qualifying angiographic follow-up. Angiographic percent diameter 
stenosis was defined as (1 - (Minimal lumen diameter (MLD) - reference vessel diameter)) 
/100.  Late luminal loss (LLL) was defined as the MLD immediately after the procedure 
minus the MLD at 6-month follow-up (figure 3). In patients with multiple stents implanted, a 
mean LLL per patient was calculated to compare between groups of training and control. 
Otherwise, the mean LLL per stent was used to compare stent-dependent LLL between 
groups. 
Two cardiologists independently interpreted the images in a blinded manner. Disagreement 
was resolved by reanalysis and consensus. The intraobserver variability of absolute vessel 
dimensions for 20 randomly selected measurements was 0.09 mm. The interobserver 
variability of absolute vessel dimensions was 0.11 mm. 
 
 
Figure 2. Original registration of a quantitative coronary angiography analysis. 
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Figure 3. Late luminal loss. 
 
3.4 Aerobic capacity 
One week after PCI the subjects performed a symptom-limited ergospirometry to assess 
safety, to calculate the target heart rate for training and to measure peak oxygen uptake 
(VO2). Tests were done on an upright, electrically braked cycle ergometer (Model KEM III, 
Mijnhardt, S.V.Bunnik, The Netherlands) using a 20 Watt/minute ramp protocol. The patients 
were asked to exercise to exhaustion. Gas exchange data were collected continuously with an 
automated breath-by-breath system (System 2001, medical Graphics Corporation, St.Paul, 
Minn., USA).  
 
3.5 Endothelial function 
Endothelium-dependent and endothelium-independent dilation of the brachial artery was 
measured at 7 days and at 6 months after PCI. All examinations were done by the same 
operator with a 12-MHz ultrasound Doppler probe (Vivid 7 System, GE Vingmed Ultrasound, 
Horten, Norway), according to the guidelines by Corretti et al. (3). Vasoactive medication was 
withheld for 48 hours. Imaging of the brachial artery was done above the antecubital fossa in 
the longitudinal plane. A segment with clear anterior and posterior intimal interfaces between 
the lumen and the vessel wall was selected for continuous 2D greyscale imaging and 
Luminal diameter after 
stent implantation  
Luminal diameter after 6 
months 
Late luminal loss 
minus
=
  21
measuring of the diameter before inflation of a pneumatic cuff on the upper arm to 250 mm 
Hg for 5 minutes.  Flow-mediated vasodilation (FMD) was expressed as percentage dilation 
from baseline diameter to that observed 1 minute after cuff release. 
Endothelium-independent dilation was measured 3 minutes after administration of 0.4 mg 
nitroglycerin sublingually. Five cardiac cycles were analyzed and averaged for each scan.  All 
scans were analyzed twice with EchoPACtm (GE Vingmed Ultrasound) by to blinded 
investigators. 
 
 
3.6 Heart Rate Variability 
HRV measures were obtained from a 3-channel portable Holter worn for 24 hours as 
recommended by the task force of the European Society of Cardiology and the North 
American Society of Pacing and Electrophysiology (32) at baseline (1 week after PCI) and at 
6 months. The commercially available MT-200 Holter System from Schiller (Switzerland) 
with the MT-210 Analysis Software Version 1.0.0 was used to analyse time and frequency 
domain measures of HRV. In a continuous 24 hours ECG recording, each R wave or QRS 
complex is detected and labelled as normal sinus (N) or abnormal. The complete 24 hour 
registrations were carefully edited using visual checks and manual corrections of incorrect 
designated complexes by an experienced medical technologist kept unaware of study data. 
Three time periods, 24 hours, daytime (09:00-21:00) and night time (00:00- 06:00) were 
analyzed. For quality reasons only 5-minute segments of the recording with 95% of normal 
beats were included. Since many time domain measures correlate closely with others, four 
indices were chosen as recommended by the task force: the standard deviation of all NN 
intervals in the entire 24 hour registration (SDNN), the triangular interpolation of NN interval 
histogram (TINN), the standard deviation of the average normal RR intervals for 288 5-
minute segments of a 24 hour ECG recording (SDANN) and the root mean square of 
differences between successive NN intervals (RMSSD).  
Additionally, frequency domain analysis was performed using a non-parametric method (fast 
Fourier transformation). The power spectrum was quantified into various frequency bands as 
standards (32). The frequency domain indices total-power, ultra low frequency (ULF), very 
low frequency (VLF), low frequency (LF), high frequency (HF), very high frequency (VHF) 
and the LV/HF-ratio were reported. 
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3.7 Markers of inflammation and endothelial cell activation 
Blood sampling protocol 
Blood samples were collected by standard venipuncture from the left median cubital vein 
before angiography, immediately after PCI, and 3 hours, 24 hours, 3 days, 7 days, 6 weeks 
and 6 months after PCI. EDTA (ethylenediaminetetraacetic acid) plasma tubes were 
immediately stored on ice and separated within 30 minutes by centrifugation at 4º C and 
1800g for 15 minutes to obtain platelet-poor plasma. Samples were stored at -80º C until 
analysis and thawed only once. 
Biochemical measurements 
CRP concentrations were measured by a high-sensitivity particle-enhanced 
immunoturbidimetric method by the use of Roche Modular P automated clinical chemistry 
analyzers (Roche Diagnostics, Basel, Switzerland) and reagents of Tina-quant CRP (latex) 
assay (Roche Diagnostics). Plasma concentrations of IL-6, IL-10, PTX3, TNF, VCAM-1, E-
selectin, P-selectin, MCP-1/CCL2, RANTES/CCL5, CCL19, CCL21, IL-8/CXCL8 and 
CXCL16 were quantified by enzyme immunoassays (EIAs) obtained from R&D Systems 
(Minneapolis, MN). Plasma concentrations of vWF were analyzed by EIA using antibodies 
from DakoCytomation (Glostrup, Denmark) as previously described (33). Plasma 
concentrations of CD40L were analyzed by EIA provided by Bender MedSystems GmbH 
(Vienna, Austria). The intra- and inter-assay coefficients of variation were <10% for all 
assays.  
 
3.8 Statistics 
Sample size calculation and randomization 
LLL six month after stent implantation is usually between 0 and 0.8 mm (21). In the Exercise 
Training Intervention After Coronary Angioplasty (ETICA)-trial LLL following PCI was 0.54 
mm smaller in the training group compared to the control group (34). Taking into account that 
30 to 50% of patients would receive a DES, we chose an estimated difference in mean lumen 
loss between groups of 0.35 mm. To obtain 80% power for detection of this difference, 
assuming a standard deviation of 0.4 mm in each group, a sample size of 40 patients was 
needed.  
Block randomization (four blocks of 10 individuals, with equal number of treatments) was 
used to achieve evenly balanced treatment group numbers at the end of each block. The order 
of treatments within the block was randomly permuted by a computer-generated sequence.  
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Statistical analysis 
All data were statistically analyzed by SPPS 15.0 (SPSS Inc., Chicago, Illinois). The 
Kolmogorov-Smirnov test and visual inspection of QQ-plots were used to test for normal 
distribution of continuous data.  
Main outcome data with skewed distribution (late luminal loss, FMD and CRP) are reported 
as median and interquartile range. Normally distributed data are expressed as mean ± standard 
deviation (SD) or absolute numbers (n). Skewed data of HRV measures were logarithmically 
transformed to correct for skewness before statistical analysis. In the analysis of HRV 
measures a linear regression model was applied to test for treatment effects with adjustment 
for baseline factors 
Comparisons between groups were analyzed by two-sided t-test or Mann-Whitney U test as 
appropriate. Comparison of categorical variables was generated by the Pearson chi-square test 
or Fisher`s exact test. Spearman correlation was used to calculate correlation coefficients. 
Analysis of variance with repeated measures (ANOVA) was used to test for differences of 
biomarker levels between treatment groups over time. A linear mixed-effect model (R-
statistics version 2.9.1.2009) was applied to analyze the changes in plasma levels of 
inflammatory mediators over time as the dependent variables and fixed effects for stent type, 
access site and use of glycoprotein IIb/IIIa-inhibitors.   
All tests were 2-tailed and a p-value below the 0.05 level was considered significant.  
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4.Summary of results 
 
4.1 Paper 1 
Aim: High-intensity interval training has been shown to be superior to moderate continuous 
exercise training in improving exercise capacity and endothelial function in patients with 
coronary artery disease. The objective of this study was to evaluate if this training model 
could reduce the risk of restenosis measured as late luminal loss following PCI for stable or 
unstable angina. 
Methods and results:  
We prospectively randomized 40 patients after successful PCI with implantation of a bare 
metal stent (n=30) or drug eluting stent (n=32) to a 6 months supervised high-intensity 
interval exercise training program (n=20) or to a control group (n=20). At six months 
restenosis, measured as in-segment late luminal loss of the stented coronary area, was smaller 
in the training group (0.21±0.39 mm) compared to the control group (0.55±0.41 mm, p=0.01). 
Reduction of late luminal loss in the training group was consistent with both stent types. Peak 
oxygen uptake increased in the training and control group by 17.6% and 0.5%, respectively 
(p<0.01). Flow-mediated dilation improved 6.5% in the training group and 0.3% in the 
control group (p=0.01). Levels of high-sensitivity CRP decreased in the training group by 
0.8±1.6 mg/l and increased by 0.1±0.9 mg/l in the control group (p=0.03). 
Conclusions: Regular high-intensity interval exercise training was associated with a 
significant reduction in late luminal loss in the stented coronary segment. This effect was 
associated with increased aerobic capacity, improved endothelium function and attenuated 
levels of CRP.  
 
 
4.2 Paper 2 
Aim: Low time domain measures of heart rate variability have been shown to predict 
outcome after myocardial infarction. The predictive value of heart rate variability, when 
measured in patients with coronary artery disease without myocardial infarction is less clear. 
Further, little is known about the mechanisms how autonomic imbalance affects outcome. 
Methods and results: Forty patients following PCI with stent implantation for angina 
pectoris were prospectively randomized to a six months supervised high-intensity interval 
training program (n=20) or to a control group (n=20). All patients underwent 24-hour Holter 
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monitoring, measurement of peak oxygen uptake and ultrasound assessment of endothelial 
function at baseline and at six months. 
At baseline there were no significant differences between groups. In the training group all 
time domain indices and the frequency domain indices, total power and ultralow frequency of 
heart rate variability, increased significantly during the training period. Mean heart rate 
decreased significantly. In the control group only the root mean square of differences between 
successive NN intervals (ln RMSSD) increased significantly.  
Changes in standard deviations of the average NN intervals (SDANN) and lnRMSSD were 
significantly correlated to changes in peak oxygen uptake (R=0.47 and 0.39; p<0.01 and 
p=0.03 respectively). Heart rate variability measures were not significantly correlated to 
endothelial function. 
Conclusions: High-intensity exercise training over 6 months significantly improved heart rate 
variability measures in patients following PCI with stent implantation. The effect on heart rate 
variability was correlated to changes in peak oxygen uptake, but not to changes in endothelial 
function. 
 
 
4.3 Paper 3 
Aim: PCI can be regarded as a model for mechanical induced plaque rupture. The objective 
of this study was to evaluate the inflammatory response to PCI in stable coronary artery 
disease by analysing plasma levels of a wide range of inflammatory mediators. 
Methods: Consecutively, we included 36 patients with stable angina pectoris after successful 
revascularization by PCI with implantation of a bare metal stent or drug eluting stent. Patients 
were followed for 7 days with serial measurements of inflammatory mediators in plasma.  
Results: CRP and Pentraxin 3 showed a statistical significant early increase after PCI peaking 
at 3 days and 3 hours, respectively. Vascular cell adhesion molecule-1 (VCAM-1) increased 
significantly with a peak at 3 days, while E-selectin showed a statistical significant gradual 
decrease. Markers of platelet mediated inflammation showed increasing (CD40 ligand) and 
decreasing (P-selectin) levels after PCI. While monocyte chemoattractant protein, CCL21 and 
CXCL16 increased rapidly in response to PCI, IL-8, CCL19 and RANTES decreased. Patients 
with drug eluting stents had significantly lower levels of VCAM-1 and RANTES compared to 
those with bare metal stents. A femoral access site was associated with higher CRP levels 
than a radial access site. The use of glycoprotein-IIb/IIIa-inhibitors was associated with 
significantly higher CD40L and RANTES levels. 
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Conclusions: Our findings underscore the complex nature of the inflammatory responses 
during PCI in stable coronary artery disease, and suggest that simultaneous measurements of 
several markers may be needed to characterize these PCI-related responses. The responses 
were only in a minor degree influenced by stent type, access site and the use of glycoprotein-
IIb/IIIa-inhibitors.  
 
 
 
4.4 Paper 4 
Aim: Increased plasma levels of inflammatory markers and markers of endothelial cell 
activation have been associated with increased risk for cardiovascular events. Exercise 
training may lower the risk for coronary heart disease by attenuating inflammation and 
improving endothelial function. The objective of this study was to evaluate effects of regular 
high-intensity exercise training on a wide range of markers of inflammation and endothelial 
cell activation.  
Material and methods: Consecutively, 36 patients were prospectively randomized to a 6 
months supervised high-intensity interval training program or to a control group following 
successful PCI for stable angina pectoris. Blood samples were drawn at baseline (before 
angiography) and at 6 months. 
Results: At 6 months, levels of the inflammatory markers IL-6 and IL-8 were reduced and 
levels of the anti-inflammatory cytokine IL-10 increased in the training group only. The 
decrease in IL-6 and CRP levels were significantly correlated with the decrease in luminal 
loss following PCI. In contrast to these anti-inflammatory effects, training had no effect on 
markers of platelet-mediated inflammation, and the effect of training on markers on 
endothelial cell activation were rather complex showing attenuating (von Willebrand factor) 
and enhancing (E-selectin and vascular cell adhesion molecule 1) effects. 
Conclusions: Regular exercise training in stable angina patients following PCI may attenuate 
some, but not all, inflammatory pathways, potentially contributing to the beneficial effects of 
exercise training on restenosis.  
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5. General discussion 
 
In paper 1 we showed that a high-intensity aerobic interval training model following PCI 
with stent implantation for angina pectoris was associated with significant reduced LLL 
suggesting that this training program is associated with a lower risk of restenosis. Reduced 
LLL in the training group was seen in patients with both BMS and DES. This effect was 
accompanied by significant improvements in aerobic capacity with higher peak oxygen 
uptake and a higher anaerobic threshold in the training group. Further, endothelial function 
measured as brachial artery reactivity improved and levels of CRP decreased significantly in 
the training group only. 
 
In paper 2 we assessed the effect of this training model on cardiac autonomic function 
reflected by both time domain and frequency domain measures of heart rate variability. We 
found that all time domain indices and the frequency domain indices, total power and ultralow 
frequency of heart rate variability, increased significantly in the training group during the 
training period. At the same time mean heart rate decreased significantly. In the control group 
only the root mean square of differences between successive NN intervals (ln RMSSD) 
increased significantly.  
The increase in SDANN and lnRMSSD were significantly positively correlated to 
improvements in peak oxygen uptake. 
 
In paper 3 we characterized the inflammatory response to PCI with stent implantation in 
thirty-six patients with stable angina, who were followed for 7 days with serial measurements 
of inflammatory mediators in plasma. We observed a complex reaction of markers of 
inflammation that underscore the complex nature of the inflammatory responses during PCI. 
The responses were only in a minor degree influenced by stent type, access site and the use of 
glycoprotein-IIb/IIIa-inhibitors. 
 
In paper 4 we further elucidated the effect of training on inflammation by expanding the 
analysis to a wide range of inflammatory markers and makers of endothelial cell activation. 
The results indicate that regular exercise training in CAD patients following PCI was 
associated with an anti-inflammatory effect reflected by significant reductions of plasma 
levels of IL-6, IL8 and an increase of IL-10. 
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The changes of plasma levels of CRP and IL-6 were significantly correlated to LLL at 6 
months, suggesting that this anti-inflammatory effect contributes to the reduction of LLL. 
Training had no effect on markers of platelet-mediated inflammation, and the effect of 
training on markers on endothelial cell activation were rather complex showing attenuating 
(von Willebrand factor) and enhancing (E-selectin and vascular cell adhesion molecule 1) 
effects. 
 
5.1 Restenosis 
The only previous trial, who has explored the effect of training on restenosis is the ETICA 
trial by Bellardinelli et al (34). The results of the current study are consistent with the results 
of the ETICA trial, which found lower residual diameter stenosis and fewer cardiac events in 
the training group. The rapid progression of the treatment of CAD in the past years have set 
limitations to the ETICA trial as it was conducted before the statin era and only approximately 
two thirds of the patients received a stent. Both stent implantation and statin treatment have 
been shown to reduce the restenosis rate (35, 36). Most patients in the current study have been 
on treatment with statins for several weeks prior to PCI. Our results indicate that a high-
intensity exercise training program for 6 months after PCI with stent implantation might 
reduce the risk of in-stent restenosis in a well-treated population with angina pectoris. The 
mechanisms of restenosis are linked to endothelial dysfunction and inflammation. The high-
intensity interval training program induced reduction of late luminal loss may be associated 
with improvements in these processes  
 
5.2 Endothelial function  
There was a significant training-induced improvement in endothelial dependent brachial 
artery reactivity in the current study.  The relationship between endothelial dysfunction in the 
brachial artery as assessed by ultrasound imaging and endothelial dysfunction noted on 
coronary angiography after acetylcholine injection is well documented (37).  
Low endothelial shear stress modulates endothelial gene expression through complex 
mechanoreception and mechanotransduction processes, inducing an atherogenic endothelial 
phenotype (38). In arterial regions with disturbed laminar flow low endothelial shear stress 
attenuates nitric oxide (NO)-dependent atheroprotection (39), promotes low-density 
lipoprotein cholesterol uptake by endothelial cells (40), promotes oxidative stress (39) and 
inflammation (41), promotes vascular smooth muscle cell migration, differentiation and 
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proliferation (42) and degradation of extracellular matrix in vascular wall and plaque fibrous 
cap (43). 
Regular exercise training increases endothelial shear stress by increasing the spatial blood 
gradient of blood velocity at the vessel wall and has the potential to reverse the pro-
atherogenic effects associated with low shear forces.  
Hambrecht et al. have shown that endurance training improves endothelium-dependent 
vasodilatation in coronary arteries by activating endothelial NO-synthase, resulting in 
increased levels of NO in coronary endothelial cells (44). Localized delivered NO may also be 
an inhibitor of  neointima formation as shown in an animal carotid balloon injury model (45), 
suggesting a potential mechanistic effect of training on LLL. Further, endothelial dysfunction 
has been used as a surrogate of atherosclerotic disease activity (46) and is an independent 
predictor of cardiovascular events and prognosis (47). In addition, impaired FMD early after 
PCI has been shown to predict the occurrence of in-stent restenosis in a prospective study 
(48), indicating a link between endothelial dysfunction and neointimal growth.   
 
5.3 Inflammatory markers and markers of endothelial cell activation 
Large epidemiological studies have shown an inverse relationship between physical activity 
and inflammation (49-51) suggesting that attenuated systemic inflammation may be one of the 
mechanisms through which physical activity leads to a reduction in cardiovascular risk. 
Current American guidelines have implied CRP as a risk marker and conclude that it is 
reasonable to measure hs-CRP as an adjunct to the major risk factors to further assess absolute 
risk for coronary disease primary prevention (52). These recommendations are based on CRPs 
ability to independently predict the risk of cardiovascular events (53). Further, serum-levels of 
CRP before PCI (54) and the response of CRP to PCI have been shown to be associated with 
restenosis (19). The reduction of hs-CRP levels and IL-6 in the training group reported in the 
first and fourth paper indicates an anti-inflammatory effect of regular training. This 
modulation of the inflammatory profile may be operative for the training induced reduction of 
LLL as reductions of plasma levels of both CRP and IL-6 were associated with less LLL at 6 
months.  
The attenuation of inflammation in the training group is in accordance with previous studies 
showing a training induced reduction in the inflammatory response both in patients with CAD 
and heart failure (55, 56). Previous studies have also documented that CRP decreases NO 
production and increases endothelin-1 production by endothelial cells leading to endothelial 
dysfunction (57). 
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Experimental studies using transgenic mouse models indicate a cause response relationship 
between CRP and atherosclerotic disease (58). Recently, Xing et al. demonstrated that 
neointima formation after vascular injury is exaggerated in human CRP transgenic mice (59), 
implying an potential role for CRP in the development of restenosis. 
In paper 4 we elucidate the effect of long-term training on inflammation and expanded the 
analysis to selected markers of inflammation and markers of endothelial cell activation. We 
found that the training group, but not the control group, showed a significant decrease in 
plasma levels of the inflammatory mediators IL-6, IL-8 and CCL21 as well as an increase in 
plasma levels of the anti-inflammatory cytokine IL-10, and as for IL-6 and IL-8, the 
difference in changes between the two study groups reached statistical significance.  
The changes in IL-6 and CRP levels were significantly correlated with LLL following PCI, 
suggesting a possible link between the effect of aerobic interval training on restenosis 
following PCI and the anti-inflammatory net effects of such physical activity.   
Previous studies examining the effect of exercise training on markers of inflammation 
in different populations with cardiovascular risk factors have been diverging, and several of 
these studies were not randomized (60-69). In a study comparing PCI with exercise training, 
regular physical exercise training was associated with a significant reduction of both 
inflammatory markers and ischemic events (70). In addition, Peschel et al. found that high-
frequency and duration exercise training reduced the expression of adhesion molecules on 
monocytes in stable CAD patients, while a less intensive home-based program did not (71), 
indicating that the intensity of the training program matters with regard to the anti-
inflammatory effect. However, although training and PCI have been compared, no previous 
randomized studies have prospectively examined the effect of exercise training on 
inflammation in CAD patients following PCI. Here, we show a significant difference in 
changes in plasma levels of the prototypical inflammatory cytokines IL-6 and IL-8 between 
the training and the control group, with a significant decrease in these cytokines during 
exercise training, accompanied by an increase in the anti-inflammatory cytokine IL-10. Our 
findings further support an anti-inflammatory potential of exercise training in CAD patients, 
including the follow-up period after PCI.  
The decrease in IL-8 levels, being a pro-atherogenic chemokine, may be of interest, 
and notably, the regulation of IL-8 seems to be closely related to oxidative stress and hypoxia, 
that could have been attenuated by training. The decrease of both IL-6 and CRP levels 
supports that aerobic interval training attenuates the inflammatory IL-6-CRP pathway. Plasma 
levels of IL-6 are strongly associated with future cardiac events and mortality in patients with 
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stable CAD (72), and peri-procedural plasma CRP and IL-6-levels have been associated with 
the risk of restenosis (19, 73). IL-6 has been shown to promote vascular smooth muscle cell 
proliferation, and our findings in the present study, showing a strong correlation between the 
decrease in plasma levels of IL-6 and the reduction of late luminal loss in the training group 
following PCI, may further relate IL-6 to the restenosis process, a process that seems to be 
attenuated by exercise training.  
 While most studies on the effects of exercise training on inflammation in CAD 
patients have been focused on a few central mediators, we in the present randomized trial 
examined a wide range of inflammatory mediators. Thus, while training had attenuating 
effects on some central inflammatory markers (i.e., IL-6 and IL-8), aerobic interval training 
had no effect on markers of platelet-mediated inflammation. Moreover, whereas training 
decreased IL-8 and CCL21 levels, plasma concentration of most of the chemokines that were 
examined (i.e., RANTES, MCP-1, CXCL16, CCL19) did not change during the training 
period. Finally, whereas exercise training has been shown to improve endothelial function in 
CAD patients, our findings in the current study may suggest a more complex effect of training 
on endothelial cells, inducing both attenuating (i.e. decreased vWF levels) and enhancing (i.e., 
increased VCAM-1 and E-selectin levels) effects on markers of endothelial cell activation.  
 
5.4 Aerobic capacity 
Exercise capacity measured as VO2 consumption is the strongest independent predictor of all-
cause and cardiovascular mortality compared with other established risk factors in patients 
with cardiovascular disease (74).  The substantial increase both in peak VO2 (17.6 %), 
anaerobic threshold (23.3 %) and maximal work load (17.2%) in the training group is 
comparable with the results from previous studies applying a high-intensity interval training 
program (12). Exercise training has therefore a potential beneficial prognostic effect in 
addition to the reduction in in-stent restenosis rate in this patient population. 
 
5.5 Cardiac autonomic function 
Coronary artery disease is associated with cardiac autonomic imbalance reflected by low heart 
rate variability (75). Low HRV has been shown to predict mortality after myocardial 
infarction (76) and is a risk marker for cardiac events in the general population (77). The 
predictive value of HRV for myocardial infarction or cardiovascular mortality, when 
measured in patients with angina pectoris without previous myocardial infarction is not clear.  
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Myocardial infarction and heart failure lead to activation of the sympathetic and the renin-
angiotensine-aldosterone system, which both depress HRV (78, 79). Previous MI and 
congestive heart failure were thus exclusion criteria for this study. 
The indices SDNN and TINN are estimates of overall HRV. SDANN reflects long-term 
components of HRV mediated by both sympathetic and parasympathetic influences, while 
RMSSD reflects short-term components of HRV mediated by parasympathetic respiratory 
variations. 
After 6 months of HIIT HRV was significantly improved reflected by an increase in all time 
domain indices and several frequency domain measures. The increase in time domain 
measures was consistent at day-and night time. The observed increase in SDNN of 27 ms or 
22% was much larger than the average increase in SDNN of 9 ms or 16% seen in a current 
published meta-analysis (31) and might be the direct effect of this efficient training program 
over a period of six months. 
The improvement in the time domain indices SDANN and rMSSD were significantly 
correlated to an increase in physical fitness, but not to improvements in endothelial function. 
The significant reduction in mean heart rate and increase in rMSSD in the training group 
indicates a shift towards increased parasympathetic and decreased sympathetic nervous 
activity. 
The evaluation of the effect of training on HRV in randomized controlled trials is limited by 
the heterogeneity of patient populations included and methods used to measure HRV (31). 
The present study differs from these trials in that patients after MI and congestive heart failure 
had been excluded and a modern high-intensity interval training program was applied, that 
seem to be more effective compared to a traditionally moderate continuously intensity 
program in improving aerobic exercise capacity and endothelial function in different patient 
populations (12-14). 
However, this potential beneficial effect is limited by the fact that there is no sufficient 
evidence to determine whether changes in HRV indices translates into clinical benefit nor 
what can be regarded a clinically significant improvement in HRV.  
 
5.6 Effects of training 
Regular high-intensity training has multifactorial effects in patients with CAD including 
improved risk factor profile. Exercise training as part of a lifestyle-intervention has been 
shown to attenuate the progression of coronary stenosis (80-82). However, the regression of 
coronary plaques was comparatively small and makes it difficult to explain the substantial 
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increase of myocardial perfusion seen on scintigraphy (83) and the risk reduction in cardiac 
events in these trials (81). Improvement of myocardial perfusion may be achieved 
independently from regression of stenotic lesions mediated by improved endothelial function. 
By increasing local endothelial shear stress regular exercise training has the potential to shift 
endothelial function and structure to an anti-atherosclerotic phenotype attenuating formation 
and progression of atherosclerotic plaques and vascular remodelling. 
 
5.7 Limitations 
Although this randomized, controlled evaluation of the effect of high-intensity interval 
training demonstrated favourable angiographic and clinical outcomes in the training arm, one 
should be careful when interpreting the results due to the small sample size and rather large 
standard deviations. A further limitation is the heterogeneity of stents implanted. There are 
differences between different types of BMS or DES with regard to the degree of LLL that 
might have influenced the results. However, the training effect was consistent in both the 
BMS and the DES patients. Moreover, the present study was performed in patients with 
angina pectoris following PCI, and this situation may not necessarily be extrapolated to the 
general CAD population. The actual patients had moderate CAD with a modest inflammatory 
load. The inflammatory response to the PCI with stent implantation and the subsequent 
reparative process may overwhelm the inflammatory response of the underlying 
atherosclerotic process which in turn may explain the modest findings on inflammatory 
markers. In addition the patients were all on statins which are known to have potent anti-
inflammatory properties.  
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6. Conclusions and implications 
 
1. Our results imply that a high-intensity interval training program may reduce in-stent 
restenosis following PCI with stenting. Further, training resulted in a marked increase in 
aerobic capacity, work load and improved endothelial function, which are known to be 
associated with a more favourable prognosis. 
 
2. A six months high-intensity interval training program results in favourable effects on 
cardiac autonomic function. However, if these effects translate into clinical benefits is 
currently not known. A large prospective study evaluating HRV with regard to intervention is 
needed to develop a robust prediction model that can be used in clinical practice. 
 
3. PCI and stenting can be regarded as a model for mechanical induced plaque rupture. The 
trauma to the vessel wall leads to a complex response of circulating plasma levels of markers 
of inflammation and endothelial cell activation. Simultaneous measurements of several 
markers may be needed to characterize these PCI-related responses. Forthcoming studies 
should investigate if the inclusion of several of these markers will give more prognostic 
information than the measurement of standard inflammatory markers such as CRP. 
 
4. In clinical stable patients revascularized with PCI and on optimal medical treatment a 6 
months high-intensity interval training program attenuates some, but not all, inflammatory 
pathways, potentially contributing to the beneficial effects of exercise training on restenosis.  
 
 
The findings are hypothesis generating for larger randomised trials in this population. If the 
results on restenosis can be confirmed in larger studies, high-intensity interval training 
programs should become a natural part of the treatment program for these patients.  
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8. Errata 
Paper 2: 
Table 1, correct number of patients with unstable angina in training group is 3(15). 
Paper 2:  
Discussion, “... to be associated with an activation of the sympathetic and the renin-
angiotensine-aldosterone system, which depresses HRV [7,8]. 
Paper 4: 
Results, plasma levels of chemokines, last sentence 
“…and MCP-1 did not change significantly during follow-up in neither groups (Table 2).” 
 
